![Quan Zhou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Quan Zhou
Director/Board Member at Beijing Biostar Pharmaceuticals Co. Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
Kai Lin Liu | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 4 years |
Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 years |
Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 years |
De Qing Tan | M | 57 |
Southwest Jiaotong University
| 22 years |
Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 years |
Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 years |
Zuo Ping Xiao | M | 49 |
Southwest Jiaotong University
| 17 years |
Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
Hui Wu Wang | M | 52 |
Southwest Jiaotong University
| 15 years |
Guang Wu | M | 66 |
Southwest Jiaotong University
| 16 years |
Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hong Yu Zhuo | M | 45 |
Southwest Jiaotong University
| 7 years |
Lei Lei | M | 40 |
Southwest Jiaotong University
| 6 years |
Shun Shen | M | 51 |
Southwest Jiaotong University
| 7 years |
Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Ying Wang | M | 56 |
Southwest Jiaotong University
| 3 years |
Xing Zhang | M | 33 |
Southwest Jiaotong University
| 4 years |
Xu Dong Chen | M | 57 |
Southwest Jiaotong University
| 3 years |
Peng Wang | M | 43 |
Southwest Jiaotong University
| 3 years |
Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
Xian Jun Wang | M | 53 |
Southwest Jiaotong University
| 1 years |
Yao Chao Chen | M | 39 |
Southwest Jiaotong University
| 4 years |
Wu Li Gao | F | 40 |
Southwest Jiaotong University
| 4 years |
Hua Wang | M | 37 |
Southwest Jiaotong University
| 4 years |
Jing Xiang | M | 48 |
Southwest Jiaotong University
| 3 years |
Yu Mao | M | 37 |
Southwest Jiaotong University
| 4 years |
Hang Wei | M | 47 |
Southwest Jiaotong University
| 3 years |
Xiao Li Shi | F | 38 |
Southwest Jiaotong University
| 4 years |
Xiao Long Wu | M | 50 |
Southwest Jiaotong University
| 2 years |
Sheng Xiang Lei | M | 59 |
Southwest Jiaotong University
| 3 years |
Erke Huang | M | 36 |
Southwest Jiaotong University
| 4 years |
Chun Hui Zhang | F | 37 |
Southwest Jiaotong University
| 3 years |
Gang Wu | M | 46 |
Southwest Jiaotong University
| 4 years |
Xin Pan | M | 36 |
Southwest Jiaotong University
| 4 years |
Yong Ye | M | 49 |
Southwest Jiaotong University
| 3 years |
Min Xiang | F | 52 |
Southwest Jiaotong University
| 4 years |
Li Li Ding | F | 38 |
Southwest Jiaotong University
| 4 years |
Jing Yu Jin | M | 58 |
Southwest Jiaotong University
| 3 years |
Cha Hua Lin | F | 46 |
Southwest Jiaotong University
| 4 years |
Yu Jiang Lu | M | 52 |
Southwest Jiaotong University
| 2 years |
He Jiang | M | 58 |
Southwest Jiaotong University
| 1 years |
Zhen Ling Wang | M | 43 |
Southwest Jiaotong University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 48 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Quan Zhou
- Personal Network